Bayer AG Stock CBOE EUROPE EQUITIES - EUROPEAN EQUITIES (NL)
Stocks
BAYNd
DE000BAY0017
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.66 EUR | +2.42% |
|
+2.48% | -33.31% |
| 06-19 | Dax Needs Fresh Catalysts Above 25,000 Points | DP |
| 06-19 | Sadif Investment Analytics Downgrades Bayer to Sell, Lifts PT | MT |
| Market Cap | 37.17B 42.64B 34.43B 32.23B 60.45B 4,023B 60.81B 408B 158B 1,980B 160B 157B 6,876B | P/E 2026 * |
16.1x | P/E 2027 * | 12.1x |
|---|---|---|---|---|---|
| Enterprise Value | 68.87B 78.99B 63.79B 59.71B 112B 7,453B 113B 757B 293B 3,669B 297B 290B 12,739B | EV / Sales 2026 * |
1.51x | EV / Sales 2027 * | 1.41x |
| Free-Float |
100% | Yield 2026 * |
0.58% | Yield 2027 * | 1.96% |
Last Transcript: Bayer AG
| 1 week | +4.06% | ||
| Current month | +3.86% | ||
| 1 month | -2.22% | ||
| 3 months | -2.18% | ||
| 6 months | +4.90% | ||
| Current year | +1.80% |
| 1 week | 35.67 |  | 38.58 |
| 1 month | 32.9 | | 39.46 |
| 3 years | 18.39 | | 53.79 |
| 5 years | 18.39 | | 67.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 59 | 01/06/2023 |
Judith Hartmann
DFI | Director of Finance/CFO | 57 | 01/06/2026 |
Christian Rommel
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/02/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
André van Broich
BRD | Director/Board Member | 56 | 01/04/2012 |
| Director/Board Member | 66 | 01/04/2022 | |
Heike Hausfeld
BRD | Director/Board Member | 60 | 01/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.42% | +2.48% | +39.95% | -27.09% | 42.64B | |
| -1.21% | -3.04% | +44.03% | +142.51% | 980B | |
| -2.48% | -5.18% | +52.47% | +39.36% | 550B | |
| -2.14% | -4.94% | +16.83% | +58.18% | 382B | |
| +0.25% | -3.09% | +23.33% | +16.78% | 316B | |
| +0.61% | -1.69% | +27.35% | +14.22% | 272B | |
| +0.22% | -3.10% | +24.67% | +30.69% | 268B | |
| +4.59% | +1.98% | -38.43% | -46.41% | 199B | |
| -1.19% | -4.95% | +16.68% | +48.70% | 182B | |
| -1.35% | -1.46% | +14.06% | +59.46% | 154B | |
| Average | -0.30% | -3.02% | +22.10% | +33.64% | 366.93B | |
| Weighted average by Cap. | -0.78% | -3.68% | +29.62% | +62.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45.54B 52.23B 42.18B 39.48B 74.05B 4,928B 74.5B 500B 194B 2,426B 196B 192B 8,423B | 46.81B 53.69B 43.35B 40.58B 76.11B 5,066B 76.57B 514B 199B 2,493B 202B 197B 8,658B |
| Net income | 2.17B 2.49B 2.01B 1.88B 3.53B 235B 3.55B 23.86B 9.25B 116B 9.35B 9.15B 402B | 3B 3.44B 2.77B 2.6B 4.87B 324B 4.9B 32.92B 12.76B 160B 12.9B 12.62B 554B |
| Net Debt | 31.7B 36.35B 29.36B 27.48B 51.54B 3,430B 51.85B 348B 135B 1,688B 136B 134B 5,863B | 28.63B 32.83B 26.51B 24.82B 46.55B 3,098B 46.83B 315B 122B 1,525B 123B 121B 5,295B |
Employees
-
Sector
Pharmaceuticals
Calendar
| Date | Price | Change |
|---|---|---|
| 19/06/26 | 37.66 € | +2.42% |
| 18/06/26 | 36.77 € | -2.96% |
| 17/06/26 | 37.89 € | +5.37% |
| 16/06/26 | 35.96 € | -0.50% |
| 15/06/26 | 36.14 € | -0.14% |
- Stock Market
- Stocks
- BAYN Stock
- BAYNd Stock
Select your edition
All financial news and data tailored to specific country editions
